BOSTON, Apr 06, 2009 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ: OFIX) (the Company) today announced
that its subsidiary, Orthofix Inc., has been awarded accreditation
status by the Accreditation Commission for Health Care, Inc., (ACHC) for
the provision of Durable Medical, Prosthetics, Orthotics and Supplies
(DMEPOS) services.
ACHC is a national not-for-profit corporation that was developed by home
care and community-based providers to help companies improve business
operations and the quality of patient care. The organization provides
accreditation programs for various providers, including home health and
hospice agencies, home infusion companies, home care aides, specialty
pharmacies and home medical suppliers. Referring to the value of
accreditation, ACHC President Tom Cesar indicated "The survey process
leads an organization to examine its policies and practices continually
to clarify its strengths and improve any weaknesses."
Accreditation is a voluntary activity where healthcare organizations
submit their internal policies, processes and patient care delivery
systems for peer review against national standards. By attaining
accreditation, Orthofix Inc. has demonstrated its commitment to maintain
a higher level of competency and strive for excellence in its products,
services, and customer satisfaction.
"Orthofix Inc. is committed to quality product development and customer
service as demonstrated by the ACHC accreditation as well as our history
of meeting ISO 13485 standards," said Alan Milinazzo, President and CEO
of Orthofix International. "We are proud to have achieved this very
important accreditation, which is a testament to the professionalism and
quality of work demonstrated by all our employees at Orthofix Inc."
About Orthofix
Orthofix International, N.V., a global medical device company, offers a
broad line of minimally invasive surgical, and non-surgical, products
for the spine, orthopedic, and sports medicine market sectors that
address the lifelong bone-and-joint health needs of patients of all
ages-helping them achieve a more active and mobile lifestyle. Orthofix's
products are widely distributed around the world to orthopedic surgeons
and patients via Orthofix's sales representatives and its subsidiaries,
including BREG, Inc. and Blackstone Medical, Inc., and via partnerships
with other leading orthopedic product companies. In addition, Orthofix
is collaborating in R&D partnerships with leading medical institutions
such as the Orthopedic Research and Education Foundation, Rutgers
University, Texas Scottish Rite Hospital for Children and National
Osteoporosis Institute. For more information about Orthofix, please
visit www.orthofix.com.
Forward-Looking Statements
This communication contains certain forward-looking statements under the
Private Securities Litigation Reform Act of 1995. These forward-looking
statements, which may include, but are not limited to, statements
concerning the projections, financial condition, results of operations
and businesses of Orthofix and its subsidiaries and are based on
management's current expectations and estimates and involve risks and
uncertainties that could cause actual results or outcomes to differ
materially from those contemplated by the forward-looking statements.
Factors that could cause or contribute to such differences may include,
but are not limited to, risks relating to the expected sales of its
products, including recently launched products, unanticipated
expenditures, changing relationships with customers, suppliers and
strategic partners, risks relating to the protection of intellectual
property, changes to the reimbursement policies of third parties,
changes to and interpretation of governmental regulation of medical
devices, the impact of competitive products, changes to the competitive
environment, the acceptance of new products in the market, conditions of
the orthopedic industry and the economy, corporate development and
market development activities, including acquisitions or divestitures,
unexpected costs or operating unit performance related to recent
acquisitions and other factors described in our annual report on Form
10-K and other periodic reports filed by the Company with the Securities
and Exchange Commission.
SOURCE: Orthofix International N.V.
Orthofix International N.V.
Dan Yarbrough, 617-912-2903
Vice President of Investor Relations
danyarbrough@orthofix.com
Copyright Business Wire 2009